possess the same reactivity toward oxime formation. Thus, their
differential performance in promoting MOrPH formation
(Fig. 2, Fig. S2, S3 (ESIz)) can be attributed to the intein
splicing properties of their amino-thiol moieties. The poor
performance of the cysteine-based 1 can be rationalized con-
sidering the stringency of the applied conditions (SP at 15 mM,
no thiol catalyst added, short incubation time) compared to
EPL protocols, which typically involve high concentrations of
thiol catalysts (up to 200 mM) as well as longer reaction times.11
More surprising was the inefficiency of 2 to induce intein
splicing given that thiophenol and related aromatic thiols,
including 4-aminothiophenol, are effective catalysts for NCL
reactions.10 We conclude that the ortho amino group drastically
reduces the nucleophilicity of the neighboring thiol in the
context of intein splicing, possibly due to steric effects and/or
unfavorable hydrogen bonding interactions with the protein. By
comparison, the MOrPH-forming ability of 3 stems from the
superior intein splicing properties of its 2-amino-benzylthiol, a
structure which has never been described in the context of
thioester- or intein-mediated ligations.15 Clearly, such a struc-
ture preserves the nucleophilicity of the benzylic thiol while
placing the amino group at a viable distance for acyl transfer via
a six-membered ring intermediate.
Fig. 3 Extent of 3-induced protein splicing for 18 variants from the
library of precursor proteins with randomized 5mer (A) and 8mer (B)
target sequences. See also Tables S2 and S3 in ESI.z
Science Foundation grant CHE-0840410. We thank Peter G.
Schultz for kindly providing pEVOL_pAcF vector.
Notes and references
1 E. M. Driggers, S. P. Hale, J. Lee and N. K. Terrett, Nat. Rev.
Drug Discovery, 2008, 7, 608–624.
To investigate the possibility of diversifying the macrocycle
structures by varying their genetically encoded moiety, we
constructed two biosynthetic precursor libraries with randomized
5mer and 8mer target sequences, namely CBD-(pAcF)-X4T-GyrA
and CBD-(pAcF)-X7T-GyrA, where X corresponds to a fully
randomized position (NNK codon). About 5000 recombinants
from each library were pooled together and expressed in
E. coli. SDS-PAGE revealed only small amounts of premature
splicing during expression (o15–20%). For both libraries,
3 induced more than 35% and 60% splicing of the full-length
proteins after 5 hours and 16 hours, respectively. To establish
the occurrence of macrocyclization, 18 randomly chosen
recombinants from each library were isolated and characterized.
Remarkably, all the recombinants from the 5mer BP library and
all but one of the 18 recombinants from the 8mer BP library
yielded the desired hybrid macrocycle (Tables S2 and S3,
ESIz). For only 2/18 of the 5mer BPs and 1/18 of the 8mer
BPs a small amount of acyclic product (15–25%) was observed.
Notably, the majority of the 5mer and 8mer BP variants (63% and
58%, respectively) underwent more than 50% splicing after
overnight incubation at room temperature (Fig. 3). Most
importantly, these experiments proved the functionality of the
method across largely divergent target sequences and demonstrated
its versatility in generating diversified MOrPH structures.
2 J. M. Humphrey and A. R. Chamberlin, Chem. Rev., 1997, 97,
2243–2266; P. Li, P. P. Roller and J. Xu, Curr. Org. Chem., 2002, 6,
411–440; R. Fasan, R. L. Dias, K. Moehle, O. Zerbe, D. Obrecht,
P. R. Mittl, M. G. Grutter and J. A. Robinson, ChemBioChem,
2006, 7, 515–526; G. T. Bourne, J. L. Nielson, J. F. Coughlan,
P. Darwen, M. R. Campitelli, D. A. Horton, A. Rhumann,
S. G. Love, T. T. Tran and M. L. Smythe, Methods Mol. Biol.,
2005, 298, 151–165; V. S. Fluxa and J. L. Reymond, Bioorg. Med.
Chem., 2009, 17, 1018–1025.
3 K. T. O’Neil, R. H. Hoess, S. A. Jackson, N. S. Ramachandran,
S. A. Mousa and W. F. DeGrado, Proteins: Struct., Funct., Genet.,
1992, 14, 509–515; W. L. DeLano, M. H. Ultsch, A. M. de Vos and
J. A. Wells, Science, 2000, 287, 1279–1283.
4 C. P. Scott, E. Abel-Santos, M. Wall, D. C. Wahnon and
S. J. Benkovic, Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 13638–13643.
5 S. W. Millward, S. Fiacco, R. J. Austin and R. W. Roberts, ACS
Chem. Biol., 2007, 2, 625–634; T. Kawakami, A. Ohta, M. Ohuchi,
H. Ashigai, H. Murakami and H. Suga, Nat. Chem. Biol., 2009, 5,
888–890; C. Heinis, T. Rutherford, S. Freund and G. Winter, Nat.
Chem. Biol., 2009, 5, 502–507.
6 J. M. Smith, F. Vitali, S. A. Archer and R. Fasan, Angew. Chem.,
Int. Ed., 2011, 50, 5075–5080.
7 L. Wang, Z. Zhang, A. Brock and P. G. Schultz, Proc. Natl. Acad.
Sci. U. S. A., 2003, 100, 56–61.
8 J. Kalia and R. T. Raines, Angew. Chem., Int. Ed., 2008, 47,
7523–7526.
9 P. E. Dawson, T. W. Muir, I. Clark-Lewis and S. B. Kent, Science,
1994, 266, 776–779; J. Offer and P. E. Dawson, Org. Lett., 2000, 2,
23–26; D. L. J. Clive, S. Hisaindee and D. M. Coltart, J. Org.
Chem., 2003, 68, 9247–9254; G. Chen, J. D. Warren, J. H. Chen,
B. Wu, Q. Wan and S. J. Danishefsky, J. Am. Chem. Soc., 2006,
128, 7460–7462.
10 L. E. Canne, S. J. Bark and S. B. H. Kent, J. Am. Chem. Soc., 1996,
118, 5891–5896.
11 T. W. Muir, D. Sondhi and P. A. Cole, Proc. Natl. Acad. Sci.
U. S. A., 1998, 95, 6705–6710; T. C. Evans, J. Benner and
M. Q. Xu, Protein Sci., 1998, 7, 2256–2264.
In summary, we have developed an efficient method to
construct Macrocyclic Organo-Peptide Hybrids via a dual
oxime/intein-mediated ligation. The chemoselectivity,
bioorthogonality and catalyst-free nature of this strategy and
its demonstrated efficiency in the context of precursor target
sequences of varying length and randomized composition hold
promise toward exploiting it to generate diversified MOrPHs
tethered to a viral/cellular surface of a display system. Efforts
are ongoing to investigate this approach toward the isolation
of MOrPH-based ligands for selective protein recognition.
This work was supported by startup funds from the University
of Rochester. MS instrumentation was supported by National
12 J. A. Camarero and T. W. Muir, J. Am. Chem. Soc., 1999, 121,
5597–5598.
13 J. P. Danehy and C. J. Noel, J. Am. Chem. Soc., 1960, 82, 2511–2515.
14 M. M. Kreevoy, E. T. Harper, R. E. Duvall, H. S. Wilgus and
L. T. Ditsch, J. Am. Chem. Soc., 1960, 82, 4899–4902.
15 S. Chattopadhaya, F. B. Abu Bakar and S. Q. Yao, Methods
Enzymol., 2009, 462, 195–223.
c
This journal is The Royal Society of Chemistry 2012
Chem. Commun., 2012, 48, 1461–1463 1463